Melbourne Theranostic Innovation Centre (MTIC)

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bladder cancer2 trials
• Colorectal cancer2 trials
• Gastric and oesophageal cancer2 trials
• Lung cancer2 trials
• Ovarian cancer2 trials
• Pancreatic cancer2 trials
• Triple-negative breast cancer2 trials

Phase

• Phase 12 trials

Status

• Active, not recruiting2 trials

Lead sponsor

• Monopar Therapeutics2 trials

Running trials

• Active, not recruiting

  Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors

  NCT06617169· Phase 1· Monopar Therapeutics· Source

• Active, not recruiting

  Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

  NCT06337084· Phase 1· Monopar Therapeutics· Source